Entity Public Float of BioNexus Gene Lab Corp from 30 Jun 2018 to 30 Jun 2024

Taxonomy & unit: dei: USD
Description: The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary: BioNexus Gene Lab Corp quarterly Entity Public Float in USD history and change rate from 30 Jun 2018 to 30 Jun 2024.
BioNexus Gene Lab Corp Entity Public Float for the quarter ending 30 Jun 2024 was $8,160,000, a 88% decline year-over-year.
Source SEC data: View on sec.gov

Entity Public Float, Quarterly (USD)

Entity Public Float, YoY Quarterly Change (%)

BioNexus Gene Lab Corp Quarterly Entity Public Float (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	$8,160,000	-$58,340,000	-88%	30 Jun 2024	10-K/A	29 Apr 2025	2024	FY
Q2 2023	$66,500,000			30 Jun 2023	10-K/A	31 May 2024	2023	FY
Q4 2022	$48,487,449			31 Dec 2022	10-K/A	31 May 2024	2022	FY
Q2 2021	$41,737,068	+$41,737,068		30 Jun 2021	10-K	06 Apr 2022	2021	FY
Q2 2020	$0	$0		30 Jun 2020	10-K	30 Mar 2021	2020	FY
Q2 2019	$0	-$74,627,558	-100%	30 Jun 2019	10-K	31 Mar 2020	2019	FY
Q2 2018	$74,627,558			30 Jun 2018	10-Q	15 May 2019	2019	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.